165 related articles for article (PubMed ID: 36559537)
1. Rapid Transient Expression of Receptor-Binding Domain of SARS-CoV-2 and the Conserved M2e Peptide of Influenza A Virus Linked to Flagellin in
Mardanova ES; Kotlyarov RY; Ravin NV
Plants (Basel); 2022 Dec; 11(24):. PubMed ID: 36559537
[TBL] [Abstract][Full Text] [Related]
2. Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin.
Blokhina EA; Mardanova ES; Stepanova LA; Tsybalova LM; Ravin NV
Plants (Basel); 2020 Jan; 9(2):. PubMed ID: 32013187
[TBL] [Abstract][Full Text] [Related]
3. High-Yield Production of Receptor Binding Domain of SARS-CoV-2 Linked to Bacterial Flagellin in Plants Using Self-Replicating Viral Vector pEff.
Mardanova ES; Kotlyarov RY; Ravin NV
Plants (Basel); 2021 Dec; 10(12):. PubMed ID: 34961153
[TBL] [Abstract][Full Text] [Related]
4. Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors.
Mardanova ES; Kotlyarov RY; Kuprianov VV; Stepanova LA; Tsybalova LM; Lomonosoff GP; Ravin NV
BMC Biotechnol; 2015 May; 15():42. PubMed ID: 26022390
[TBL] [Abstract][Full Text] [Related]
5. High-Yield Production of Chimeric Hepatitis E Virus-Like Particles Bearing the M2e Influenza Epitope and Receptor Binding Domain of SARS-CoV-2 in Plants Using Viral Vectors.
Mardanova ES; Kotlyarov RY; Stuchinskaya MD; Nikolaeva LI; Zahmanova G; Ravin NV
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555326
[TBL] [Abstract][Full Text] [Related]
6. High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin.
Mardanova ES; Kotlyarov RY; Kuprianov VV; Stepanova LA; Tsybalova LM; Lomonossoff GP; Ravin NV
Bioengineered; 2016; 7(1):28-32. PubMed ID: 26710263
[TBL] [Abstract][Full Text] [Related]
7. Plant-Produced Nanoparticles Based on Artificial Self-Assembling Peptide Bearing the Influenza M2e Epitope.
Blokhina EA; Mardanova ES; Zykova AA; Stepanova LA; Shuklina MA; Tsybalova LM; Ravin NV
Plants (Basel); 2023 Jun; 12(11):. PubMed ID: 37299207
[TBL] [Abstract][Full Text] [Related]
8. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
[TBL] [Abstract][Full Text] [Related]
9. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
[TBL] [Abstract][Full Text] [Related]
10. Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
Tsybalova LM; Stepanova LA; Shuklina MA; Mardanova ES; Kotlyarov RY; Potapchuk MV; Petrov SA; Blokhina EA; Ravin NV
PLoS One; 2018; 13(8):e0201429. PubMed ID: 30138320
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding domain proteins of SARS-CoV-2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern.
Khorattanakulchai N; Manopwisedjaroen S; Rattanapisit K; Panapitakkul C; Kemthong T; Suttisan N; Srisutthisamphan K; Malaivijitnond S; Thitithanyanont A; Jongkaewwattana A; Shanmugaraj B; Phoolcharoen W
J Med Virol; 2022 Sep; 94(9):4265-4276. PubMed ID: 35615895
[TBL] [Abstract][Full Text] [Related]
12. Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice.
Mamedov T; Yuksel D; Ilgın M; Gurbuzaslan I; Gulec B; Yetiskin H; Uygut MA; Islam Pavel ST; Ozdarendeli A; Mammadova G; Say D; Hasanova G
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452461
[TBL] [Abstract][Full Text] [Related]
13. Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in
Mamedov T; Yuksel D; Ilgın M; Gürbüzaslan I; Gulec B; Mammadova G; Ozdarendeli A; Yetiskin H; Kaplan B; Islam Pavel ST; Uygut MA; Hasanova G
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835268
[TBL] [Abstract][Full Text] [Related]
14. Influence of the Linking Order of Fragments of HA2 and M2e of the influenza A Virus to Flagellin on the Properties of Recombinant Proteins.
Stepanova LA; Kotlyarov RY; Shuklina MA; Blochina EA; Sergeeva MV; Potapchuk MV; Kovaleva AA; Ravin NV; Tsybalova LM
Acta Naturae; 2018; 10(1):85-94. PubMed ID: 29713522
[TBL] [Abstract][Full Text] [Related]
15. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
[TBL] [Abstract][Full Text] [Related]
16. Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes.
Stepanova LA; Mardanova ES; Shuklina MA; Blokhina EA; Kotlyarov RY; Potapchuk MV; Kovaleva AA; Vidyaeva IG; Korotkov AV; Eletskaya EI; Ravin NV; Tsybalova LM
J Biomed Sci; 2018 Apr; 25(1):33. PubMed ID: 29631629
[TBL] [Abstract][Full Text] [Related]
17. Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand.
Wang BZ; Gill HS; Kang SM; Wang L; Wang YC; Vassilieva EV; Compans RW
Clin Vaccine Immunol; 2012 Aug; 19(8):1119-25. PubMed ID: 22647270
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.
Turley CB; Rupp RE; Johnson C; Taylor DN; Wolfson J; Tussey L; Kavita U; Stanberry L; Shaw A
Vaccine; 2011 Jul; 29(32):5145-52. PubMed ID: 21624416
[TBL] [Abstract][Full Text] [Related]
19. Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein.
Ravin NV; Kotlyarov RY; Mardanova ES; Kuprianov VV; Migunov AI; Stepanova LA; Tsybalova LM; Kiselev OI; Skryabin KG
Biochemistry (Mosc); 2012 Jan; 77(1):33-40. PubMed ID: 22339631
[TBL] [Abstract][Full Text] [Related]
20. Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.
Deng L; Kim JR; Chang TZ; Zhang H; Mohan T; Champion JA; Wang BZ
Virology; 2017 Sep; 509():82-89. PubMed ID: 28622575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
